Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials

A. Moran, B. Bundy, D. J. Becker, L. A. DiMeglio, S. E. Gitelman, R. Goland, C. J. Greenbaum, K. C. Herold, J. B. Marks, P. Raskin, S. Sanda, D. Schatz, D. Wherrett, D. M. Wilson, J. P. Krischer, J. S. Skyler, L. Pickersgill, E. De Koning, A. G. Ziegler, B. BöehmK. Badenhoop, N. Schloot, J. F. Bak, P. Pozzilli, D. Mauricio, M. Y. Donath, L. Castaño, A. Wägner, H. H. Lervang, H. Perrild, T. Mandrup-Poulsen

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)S87
JournalDiabetes Technology and Therapeutics
Volume16
Issue numberSUPPL. 1
DOIs
StatePublished - Feb 10 2014

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this

Moran, A., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Greenbaum, C. J., Herold, K. C., Marks, J. B., Raskin, P., Sanda, S., Schatz, D., Wherrett, D., Wilson, D. M., Krischer, J. P., Skyler, J. S., Pickersgill, L., De Koning, E., Ziegler, A. G., ... Mandrup-Poulsen, T. (2014). Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials. Diabetes Technology and Therapeutics, 16(SUPPL. 1), S87. https://doi.org/10.1089/dia.2014.1510